Intravenous levodopa administration in humans based on a two-compartment kinetic model

Area of Science:

• Neuroscience
• Pharmacology
• Clinical Research

Background:

• Levodopa is a primary treatment for Parkinson disease.
• Accurate plasma concentration control is crucial for neuroimaging studies.
• Previous methods lacked precision in maintaining therapeutic levodopa levels.

Purpose of the Study:

• To develop and validate a rapid, controlled levodopa infusion for neuroimaging.
• To achieve and sustain biologically relevant plasma levodopa concentrations.
• To assess safety and hormonal effects in levodopa-naive individuals.

Main Methods:

• Pharmacokinetic modeling using a two-compartment model.
• Design of a decreasing-exponential-rate infusion protocol.
• Double-blind levodopa vs. placebo infusions in healthy subjects.

Main Results:

• Achieved target plasma levodopa concentrations within 3-20% of 1200 ng/mL for 90 minutes.
• Demonstrated significant reduction in serum prolactin and increase in serum growth hormone.
• No significant adverse effects reported by volunteers.

Conclusions:

• The designed infusion method effectively achieves and maintains target levodopa plasma concentrations.
• This controlled infusion is suitable for future neuroimaging studies of neurological disorders.
• The method shows a favorable safety profile with minimal side effects.